期刊文献+

Prohibitin rs6917 C>T基因多态性与潮汕女性乳腺癌易感性的关系研究 被引量:1

Association between rs6917 C>T polymorphism of prohibitin and breast-cancer susceptibility in Chaoshan Women
下载PDF
导出
摘要 目的研究潮汕汉族女性人群中Prohibitin(PHB)基因rs6917 C〉T单核苷酸多态性(single nucleotide polymor-phism,SNP)与乳腺癌遗传易感性的关系。方法采用病例-对照研究,于2009年7-12月收集汕大医学院附属肿瘤医院231例乳腺癌住院患者和169例正常对照女性的外周血,提取全血基因组DNA,以高分辨率熔解曲线(highresolution mehing,HRM)法检测PHB基因rs6917位点基因型,计算各种基因型的乳腺癌发生风险及其95%可信区间。结果潮汕地区女性人群PHB rs6917存在两种基因型CC和TC,在乳腺癌组的频率分别为74.46%(C/C)、25.54%(T/C),在正常人群的频率分别为72.78%(C/C)和27.22%(T/C)。经统计学分析,T/C基因型携带者与C/C基因型携带者在乳腺癌发病风险上并无显著性差异(OR=1.090,95%CI=0.695~1.709,P=0.706)。结论未发现PHB基因rs6917位点SNP与潮汕汉族女性乳腺癌易感性具有相关性。 Objective To investigate the association between rs6917 C〉T single nucleotide polymorphism (SNP) of prohibitin and risk of breast cancer in Chaoshan women. Methods A case-control study was used. From July 2009 to December 2009, 23I breast-cancer patients hospitalized in cancer hospital of Shantou university medical college and 169 healthy controls were enrolled into this study. The genomic DNA was extracted from whole blood cells. Genotypes were determined determined by the high resolution melting (HRM) method. Results The PHB rs6917 C〉T genotype frequencies were 74.46% (C/C), 25.54% (T/C) in the breast cancer group and 72.78% (C/C), 27.22% (T/C) in the control group respectively. The genotype frequencies in patients and controls did not differ overall in our sample (odds ratio =1.090, 95%CI=0.695- 1.709, P = 0.706). Conclusion Our results do not lend support to the hypothesis that PHB rs6917 C〉T polymorphism contributes to risk of breast cancer in Chaoshan women.
出处 《中国医药导报》 CAS 2012年第31期16-17,20,共3页 China Medical Herald
基金 广东省科技计划资助项目(项目编号:2009B030801316) 广东省医学科研基金(项目编号:B2012258)
关键词 PROHIBITIN 单核苷酸多态性 乳腺癌 高分辨率熔解曲线 Prohibitin Single nucleotide polymophism Breast cancer High resolution melting
  • 相关文献

参考文献11

  • 1邱卫黎,李澄婷,杨郁素,陈锡文.汕头地区恶性肿瘤住院病例的疾病构成及病死率分析[J].中华肿瘤防治杂志,2006,13(9):645-647. 被引量:5
  • 2陈叙,林群,姚春花,孙河清.汕头市区已婚女性乳腺疾病相关因素分析[J].广东医学,2005,26(6):838-839. 被引量:15
  • 3Sato T,Sait,, H,Swensen J,et al. The human prohit, itin gene located on chromosome 17q21 is mutated in sporadic breast cancer [J]. Cancer Res, 1992,52: 1643-1646.
  • 4Jupe ER,Badgett AA,Neas BR. Single nueleotide pnlymorphism in prohibitin 3'untranslated region and breast-cancer suseeptihility [J]. Lancet, 2001,357: 1588-1589.
  • 5彭琳,黄裔腾,许镒洧,方裕森,霍霞.Prohibitin与乳腺癌[J].癌变.畸变.突变,2012,24(1):75-77. 被引量:4
  • 6ER Jupe,XT Liu,JL Kiehlbauch,et al. The 3' untranslated region of prohibitin and cellular immortalization [J]. Exp Cell Res, 1996,224:128-135.
  • 7Spurdle AB,Hopper JL, Chen X,et al. Prohibitin 3" untranslated region polymorphism and breast cancer risk in Australian women [J]. Lancet, 2002,360 : 925-926.
  • 8Campbell IG,Allen J,Eceles DM. Prohibitin 3 untranslated region polymorphism and breast cancer risk [J]. Cancer Epidemiology Biomarkers & Prevention, 2003,12 : 1273-1274.
  • 9Karakus N,Kara N,Ulusoy AN. Lack of association between prohibitin 3' untranslated region C→T polymurphism and breast cancer in a turkish population [J]. DNA Cell Biol, 2008,27:449-452.
  • 10Lubinski J,Seott RJ,Hamann U. The 3" untranslated region C>T polymorphism of prohibitin is a breast cancer risk modifier in Polish women earrying a BRCAI mutation [J]. Breast Cancer Res Treat,2007,104: 67-74.

二级参考文献10

共引文献21

同被引文献11

  • 1Nuell MJ, Stewart DA, Walker L, et al. Prohibitin, an evolutionarilyconserved intracellular protein that blocks DNA synthesis innormal fibroblasts and HeLa cellsfj]. Mol Cell Biol, 1991, 11(3): 1372-1381.
  • 2Jupe ER,Badgett AA,Neas BR. Single nucleotide polymorphismin prohibitin 3'untranslated region and breast-cancer susceptibility[J]. Lancet, 2001, 357 (9268): 1588-1589.
  • 3DeSantis C, Siegel R, Bandi P,et al. Breast cancer statistics,2011[J]. CA: Cancer J Clin, 2011,61: 409-418.
  • 4Jupe ER, Liu XT, Kiehlbauch JL, et al. Prohibitin in breastcancer cell lines : LOSS of antiproliferative activity is linked to3' untranslated region mutations[J]. Cell Growth Differ, 1996, 7(7):871-878.
  • 5Spurdle AB,Hopper JL,Chen X,et al. Prohibitin ^untranslatedregion polymorphism and breast cancer risk in Australianwomen[J]. Lancet, 2002, 360 (9337): 925-926.
  • 6Campbell IG, Allen J, Eccles DM. Prohibitin S'untranslatedregion polymorphism and breast cancer risk[J]. CancerEpidemiol Biomarkers Prev,2003,12 (Sup 1): 1273-1274.
  • 7Karakus N,Kara N,Ulusoy AN. Lack of association betweenProhibitin 3'untranslated region C~?T polymorphism and breastcancer in a Turkish population[J]. DNA Cell Biol, 2008,27(8):449-452.
  • 8Jakubowska A, Jaworska K, Cybulski C, et al. Do BRCA1modifiers also affect the risk of breast cancer in non-carriers?[J]. Eur J Cancer, 2009, 45(5): 837-842.
  • 9Jakubowska A, Gmnwaid J, Grrski B, et al. The 3'untranslatediregion C>T polymorphism of prohibitin is a breast cancer risk'modifier in Polish women carrying a BRCA1 mutation[J]. BreastCancer Res Treat, 2007, 104(1): 67-74.
  • 10Zhou TB, Yin SS, Huang JJ,et al. Relationship between the:prohibitin 3' untranslated region C > T gene polymorphism and cancer susceptibility-results of a meta-analysis[J]. Asian Pac;J Cancer Prev, 2012,13(7): 3319-3323.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部